Retrospective feasibility study of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children

Xinxin Yang, Matthew F. Wipperman, Sharon Nachman, Nicole S. Sampson
doi: https://doi.org/10.1101/2021.03.26.21254411

Article Information

doi 
https://doi.org/10.1101/2021.03.26.21254411
History 
  • April 26, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Xinxin Yanga,b,
  2. Matthew F. Wippermana,c,
  3. Sharon Nachmand and
  4. Nicole S. Sampsona,#
  1. aDepartment of Chemistry, Stony Brook University, Stony Brook, NY 11794-3400
  2. bChronus Pharmaceuticals, Inc., 25 Health Sciences Drive, Stony Brook, NY 11790
  3. cClinical and Translational Science Center, Weill Cornell Medicine, New York, NY 10065
  4. dDepartment of Pediatrics, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794-3400
  1. ↵#Corresponding author: nicole.sampson{at}stonybrook.edu
Back to top
Posted April 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Retrospective feasibility study of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children
Xinxin Yang, Matthew F. Wipperman, Sharon Nachman, Nicole S. Sampson
medRxiv 2021.03.26.21254411; doi: https://doi.org/10.1101/2021.03.26.21254411
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area